The Blood concentration confirmation study on silymarin formulation of process materials.
Not Applicable
- Conditions
- Healthy volunteer
- Registration Number
- JPRN-UMIN000022333
- Lead Sponsor
- FANCL Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1)Subjects who previous serious disease. 2)Subjects who are taking medicine or being treated by a doctor 3)Subjects who previous or present serious disease that affect the digestion or being treated by a doctor because of the digestive tract disease 4)Subjects who plan to receive treatment or medication by a doctor during the study 5)Subjects who has chrysanthemum allergy 6)Subjects who use specified healthy food, supplement containing silymarin within the last one month prior to the current study 7)Subjects who cannot be performed over time blood collection 8)Subjects who are judged as unsuitable for the study by the investigator for other reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood silymarin concentration after single ingestion of silymarin formulation
- Secondary Outcome Measures
Name Time Method